Observational research on sodium glucose co‐transporter‐2 inhibitors: A real breakthrough?

Benzer Materyaller

• Lessons to be Learnt from Real-World Studies on Immune-Related Adverse Events with Checkpoint Inhibitors: A Clinical Perspective from Pharmacovigilance
  Yazar:: Raschi, Emanuel, ve diğerleri
  Baskı/Yayın Bilgisi: (2020)
• Pharmacovigilance assessment of the association between Fournier’s gangrene and other severe genital adverse events with SGLT-2 inhibitors
  Yazar:: Fadini, Gian Paolo, ve diğerleri
  Baskı/Yayın Bilgisi: (2019)
• Pharmacovigilance assessment of the association between Fournier’s gangrene and other severe genital adverse events with SGLT-2 inhibitors
  Yazar:: Gian Paolo Fadini, ve diğerleri
  Baskı/Yayın Bilgisi: (2019-05-01)
• Stroke, Migraine and Triptans: From Bedside to Bench
  Yazar:: Raschi, Emanuel, ve diğerleri
  Baskı/Yayın Bilgisi: (2016)
• Thromboembolic Events with Cyclin-Dependent Kinase 4/6 Inhibitors in the FDA Adverse Event Reporting System
  Yazar:: Raschi, Emanuel, ve diğerleri
  Baskı/Yayın Bilgisi: (2021)